Royalty Report: Cannabis, Drugs, Agriculture – Collection: 266631

License Grant

Licensor hereby grants to Licensee an exclusive, world-wide, License to use the HDI Technology solely in the Cannabis Application, for the purpose of processing Cannabis Materials using the SPR in the Cannabis Industry. (The aforesaid license grant is herein sometimes referred to as the “License”).

Licensor grants an exclusive license to all Licensors Intellectual Property and patented technology and creates a partnership to bring their patented controlled cavitation process to the cannabis industry.

License Property

Licensor has the Shockwave Powerâ„¢ Reactor (SPR) rights for mixing and Heating, Hydrogenating Substances, Continuous Hydrodynamics cavitation crystallization, and four other patents.

Licensor is the owner of certain Technology called ShockWave Power™. Licensor owns Intellectual Property (“IP”, defined below), manifested in Patents, Trade Secrets, and Know How, which are embodied in Licensor's proprietary ShockWave Power Reactor/Extractor (“SPR™), and which IP is useful in a variety of industries including but not limited to those industries that extract, mix, heat, hydrate, homogenize and crystallize materials.

“Cannabis Industry” means the industry where cannabis oils and other compounds containing cannabis (“Cannabis Materials”, defined below) are derived from the cannabis sativa, cannabis indica, and cannabis ruderalis plants, including marijuana and hemp, either singularly or by mixing with substances other than cannabis oils.

“Cannabis Application” means the use of the Licensor Technology to achieve a specific result when processing only “Cannabis Materials”.

“ShockWave Power Reactor/Xtractor (SPR™”) means HDI’s proprietary device that embodies the HDI Technology in performing multiple heating, mixing and extraction functions.

“ShockWave Power Reactor/Xtractor (SPR™”) means HDI’s proprietary device that embodies the HDI Technology in performing multiple heating, mixing and extraction functions.

“Standalone SPR” means an SPR mounted on a skid containing no other equipment other than that necessary to run the SPR.

Field of Use

Illustrative, but not all, areas of use of the Licensed Technology covered by this Agreement are
(i) UV light for decarboxylation of THC
(ii) Crystallization of CBD or THC
(iii) mixing of cannabis oil with other substances to create foods, beverages, or other products which are themselves not cannabis oils
(iv) Use of Electrochemistry or UltraViolate (UV) SPR’s or other advanced oxidation materials to produce radicals for the production of CBN
(v) Hydrogenation of cannabis oils
(vi) processing of hemp oils for biofuels.
(vii) Development of an SPR for supercritical CO2

License Grant

Licensor grants an exclusive, world-wide license to the Legal use of the Licensor Technology solely for the Technology Application.

License Property

Licensor has certain intellectual property relating to oil separation technology called Density Segregation Technology, which is manifested in Patents, Trade Secrets, and Know How, which are embodied in Licensor proprietary intellectual property.

Density Segregation Technology or DST means Licensor’s proprietary devices that embodies the Licensor Technology in performing multiple separation and extraction functions.

Plant Materials means cannabis plants.

The patents are titled Method and Device for Separating a Lighter Density Fluid from a Heavier Density Fluid, and, Method and Device for Removing Bubbles from Liquid.

Field of Use

Licensee field of use is to recover Legal cannabidiol (CBD) oil and other Legal extracts from Plant Materials.

License Grant

The Canadian Licensee is appointed the exclusive distributor in Canada of the Netherland Licensors proprietary cannabis seed strains and cannabis cuttings, dried flowers and extracts. The Licensor and the Licensee will develop certain “Collaborative Products” defined as cannabis seed strains created collaboratively using the Licensors intellectual property.  The Co-Licensor has granted the Licensee an exclusive license in Canada to the Licensors intellectual property including the right to use the service mark of Serious Seeds and all of the names of the Licensors proprietary cannabis seed strains including Indica, Sativa, Hybrid and Autoflowering.

License Property

Proprietary cannabis seed strains and the cannabis cuttings, dried flowers and extracts and a cannabis seed growing operation.

Licensors  have bred an expertly curated a catalogue of classic, high quality, reliable cannabis genetics.

Field of Use

This agreement pertains to the cannabis industry.

License Grant

The Licensor grants to Licensee, a non-exclusive limited License for the right to utilize the Property solely in connection with the legal branding of the Licensed Articles and the marketing, sale and distribution of said THC branded products containing cannabis and nationwide for Pineapple Express branded products containing CBD rich hemp oil, in the specific Territory and Retail Channels via print and digital catalog and online marketing via THC.com, Pineapple Express.com, and other marketing platforms solely paid for by Licensee.  Products are any and all licensed products manufactured using cannabis infused oils, tinctures, butters, for topical and ingestible use.

License Property

Licensor has created and owns and/or controls the Property.

Property includes any and all licensed products manufactured using cannabis infused oils, tinctures, butters, for topical and ingestible use.

Field of Use

Licensee desires to obtain a License to manufacture certain items of merchandise or products bearing or otherwise utilizing the Property and to seek Licensors help to market, sell and distribute said Licensed Articles within the Territory.

License Grant

Licensor hereby grants Canadian Licensee an exclusive, sublicensable, non-transferable, non-assignable right and license to use and practice Licensor Intellectual Property Rights related to the Commercialization of the Cannabis Products and the CBD Products, and which are listed (the Defined Intellectual Property Rights) for Commercializing the Branded Products in the Territory (the License).

License Property

All Intellectual Property Rights related to the trademarks High Times and Culture.

All know-how, methods, trade secrets and other Confidential Information held by Licensor and protected by HT Intellectual Property.

All proprietary formulations for manufacturing cannabis extracts, edible cannabis and other Cannabis Products held by Licensor and protected by HT Intellectual Property.

All proprietary methods of cultivation, processing and other aspects of supply chain management owned by Licensor held by Licensor and protected by HT Intellectual Property.

“HT Technology” means know-how, methods, trade secrets and other Confidential Information held by Licensor and protected by HT Intellectual Property Rights, including formulations for manufacturing cannabis extracts, edible cannabis and other Cannabis Products and including methods cultivation, processing and other supply chain management.

Products means Cannabis Products or CBD Products.

High Times may be applied to Cannabis Products.

Culture, or upon Parties’ agreement, a new mark in substitution or in addition to Culture, may be applied to CBD Products.

Cannabis Product means Cannabis Inputs and Other Inputs that have been prepared, packaged and labelled as a consumer packaged good for sale to a consumer at the retail level.

Cannabis Input means any cannabis flowers, leaves, extract, synthesized phytocannabinoids or other cannabis used with the Other Inputs in the manufacture of a Cannabis Product.

Branded Products means any Products that carry the Licensor Branding.

CBD Product means CBD Inputs and Other Inputs that have been prepared, packaged and labelled for as a consumer packaged good for sale to a consumer at the retail level.

CBD Input means cannabidiol or cannabidiolic acid inputs that are from any flowers, leaves, extract or other sources of cannabidiol or cannabidiolic acid that are sourced from industrial hemp plants and that are not sourced from cannabis plants that are prohibited by federal law. The CBD Input is used with the Other Inputs in the manufacture of a CBD Product.

Branding means all trademarks, trade dress, trade and business names, brand names, logos, design rights, corporate names and domain names and other similar designations of source, sponsorship, association or origin, together with the goodwill symbolized by any of the foregoing, which are developed, licensed or otherwise accessed by Licensee for branding and promoting the Branded Products.

Licensor Technology means know-how, methods, trade secrets and other Confidential Information held by Licensor and protected by HT Intellectual Property Rights, including formulations for manufacturing cannabis extracts, edible cannabis and other Cannabis Products and including methods cultivation, processing and other supply chain management.

Intellectual Property Rights means all industrial and other intellectual property rights comprising or relating to (a) Branding; (b) internet domain names, whether or not Branding, registered by any authorized private registrar or Governmental Authority, web addresses, web pages, website and URLs; (c) works of authorship, expressions, designs and industrial design registrations, whether or not copyrightable, including copyrights and copyrightable works, software and firmware, data, data files, and databases and other specifications and documentation; (d) inventions, discoveries, trade secrets, business and technical information, know-how, databases, data collections, patent disclosures and other confidential or proprietary information; (e) plant varieties, strains or cultivars; and (f) all industrial and other intellectual property rights, and all rights, interests and protections that are associated with, equivalent or similar to, or required for the exercise of, any of the foregoing, however arising, in each case whether registered or unregistered, such registered rights including patent, registered plant breeders’ rights, trademark, industrial design, copyright, Plant Varieties Protection Act registrations and including all registrations and applications for, and renewals or extensions of, such rights or forms of protection under the Applicable Law of any jurisdiction in any part of the world.

Field of Use

Licensee is in the business of Commercializing the Cannabis Products through licensed cannabis dispensaries and various other channels.

The Licensee has been the worlds most recognized and trusted cannabis brand – championing the lifestyle and educating the masses on the benefits of this natural flower.  Licensee is engaged in the publication of a monthly print and on-line magazine and the production and sponsorship of trade shows and events. The strategic goal is to monetize the intellectual property and “High Times®” brand. The Licensee also contemplates various other e-commerce initiatives and licensing of the “High Times®” brand, including the development of an e-commerce store offering clothing and other products associated with cannabis.

License Grant

The Licensor and the Licensee wish to amend the License Agreement and terms to include terms, investments, assets, revenue sharing, and ownership interest of the parties for their mutual benefit under this Agreement;

The Licensor shall have the sole ownership, rights and interest in all assets, property and facilities, or products for all mutual business, new business ventures, and opportunities under the License Agreement.

The Licensee shall pay Licensing Fees & Royalties to the Licensor, after deducting and paying all operating costs, taxes, administration, professional and other fees, or other costs of business, received under the License Agreement for the marketing, manufacturing, production, sale or distribution of the Products.

License Property

Assets include but not limited to

Land, Grows and harvested crops, CA production, Extract machinery and business operations, Once Co2 Extract machine, Buildings, Tools and equipment, Inventories Cannabis or hemp, Extracts, Packaged Goods,

Plant and plant by-products 16 strains.

Field of Use

Future endeavors Non-profit medical marijuana collectives (dispensaries),

Collective to be developed (location to be later define) and run under the Cannabis Science Brand or as specified by Cannabis Science, Other for-profit business opportunities, Treatment Centers, Drug Development Programs, Media, Retail Seed Business, Laboratories and equipment.

License Grant

Sublicensor hereby grants to Sublicensee, and Sublicensee hereby accepts, a transferable, non-exclusive right and license under the Licensed Science to make or have made the Licensed Products and to use the Licenses Science Patents, Know-How, and Licensed Products in connection with the Field, including the distribution, sale, and marketing thereof, in the Territory.

The Licensed Science Sublicense granted is for the purpose of engaging in the business of treating, producing, manufacturing, marketing and selling Licensed Products.

License Property

Licensed Products means any CBD products related to the Field, whether owned by Licensor or Sublicensor or licensed by Licensor or Sublicensor now or hereafter, that are covered by any Valid Claim(s) contained in any of the Patents, and/or based on the products, processes or methods developed using the Licensed Science.

The Licensed Science as its relates to the production, methods, and products of CBD and its derivatives.

Field of Use

Field means the
(a) production and manufacturing of CBD, CBD byproducts and CBD derivatives, from non-psychoactive, low-THC cannabis sativa plant strains and cannabinoids (collectively, Cannabis), for Sale and use at retail or wholesale where permitted, including, without limitation, CBD food additives, CBD edibles, and CBD hemp variations of the foregoing;
(b) CBD-related research, teaching and education for both medical and other purposes; and
(c) all medical uses and applications of CDB.

The Field is exclusive to production, methods, and products of CBD and its derivatives, and excludes and prohibits any THC related products having measurable tetrahydrocannabinol concentration potency above 3.0% on a dry weight basis, production methods, techniques, or Know How.

License Grant

Licensor of Japan grants to Licensee of the United Kingdom under the Collaboration IP, the nonexclusive right to use the same in any way whatsoever for the purpose of the Research Collaboration including to research, make, have made and use  Research Compounds for the purposes necessary to perform its obligations and exercise its rights under the Research Plan.

This agreement is for the research and early stage development of pharmaceutical preparations based upon Research Compounds (as defined below) for the treatment of CNS and cancer indications.

License Property

Licensor has intellectual property of botanical extracts from chemovars of Cannabis sativa for the treatment of CNS and cancer indications.

Research Compounds shall mean collectively, all Selected BDCs and Selected Drug Candidates. For clarity, Research Compounds shall include Synthetic Cannabinoids synthesized under the Research Plan and which subsequently become Selected BDCs and/or Selected Drug Candidates.

Botanical Drug Candidate or BDC shall mean
—  any cannabinoid from a single chemovar of a chemically and genetically characterized Cannabis sativa plant (Phytocannabinoid) at any stage of research or development made using any extraction method and in any degree of purification in which only a single cannabinoid is present in a concentration which has the potential to be therapeutically active including, without limitation, the THC fraction and the CBD fraction separately; and
—  a combination of two or more Phytocannabinoid extracts described above containing two or more Phytocannabinoids present in concentrations such that both have the potential to be therapeutically active mixed in a precise ratio i.e. the THC and CBD fractions mixed (without other fractions) in the ratio of THC CBD of 90 10. For clarity specifically excluded from the definition of BOC is any combination of the THC and CBD fractions when mixed (without other fractions) in a ratio of CBD to THC that falls inside the range of 2575 to 7525; and,
—  any biological or chemical modification of the Phytocannabinoids in above including any metabolite or degradant.

Synthetic Cannabinoid shall mean any Phytocannabinoid produced by synthetic methods either pursuant to a Research Plan (a Type 1 Synthetic Cannabinoid) or outside of the Research Collaboration but with information resulting from the Research Collaboration (Type 2 Synthetic
Cannabinoid).

Synthetic Cannabinoid Product shall mean any pharmaceutical product containing a Type 1 Synthetic Cannabinoid (Type 1 Synthetic Product) or a Type 2 Synthetic Cannabinoid (Type 2 Synthetic Cannabinoid Product).

Synthetic Molecule shall mean a synthetic molecule whose chemistry is not based on a Phytocannabiooid but which has been developed with information resulting from the Research Collaboration and for which one or more patent.

Synthetic Molecule Product shall mean any pharmaceutical product containing a Synthetic Molecule.

Field of Use

The  fields of use are neuropsychopharmacology, with special reference to schizophrenia; cannabinoid/opioid analgesic combinations; and, oncology.

The Research Field shall mean the treatment, diagnosis, prevention, or palliation of diseases, conditions, syndromes, and maladies of the central and peripheral nervous. systems of humans and animals and cancer in humans and animals.

License Grant

By this agreement, for the Clinical Development of product candidates, Licensee may chose Product Candidates, if any, for Clinical Development. Licensee of Japan shall notify Licensor of the United Kingdom in writing of whether it is has chosen one or more Product Candidates.

Upon notice by Licensee to Licensor from time to time during the period permitted therefor pursuant to this Agreement, Licensor shall granted to Licensee under Collaboration IP and Licensor Background IP, without the need for further action by either of the Parties, an exclusive, license to make, have made, use, offer for sale, sell, import and otherwise exploit the Product Candidates referenced in such notices in the Territory in the Research Field.

Licensor of the United Kingdom grants to the Licensee of Japan under Licensor Background IP and Collaboration IP, the sole right to use the same in any way whatsoever for the purpose of the Research Collaboration including to research and use Research Compounds for the purposes necessary to perform its obligations and exercise its rights under the Research Plan but excluding the right to manufacture Research Compounds or have Research Compounds manufactured on its
behalf other than by Licensor. This right shall not be capable of sub-license.

License Property

Licensor has expertise in the research and development of pharmaceutical preparations based upon botanical extracts from chemovars of Cannabis sativa, and, has proprietary knowledge and interests in the research and development of pharmaceutical preparations based upon botanical extracts from different chemovars of Cannabis sativa in addition to that combination of botanical extracts used in SATIVEXâ„¢ oromucosal spray.

Research Compounds shall mean collectively, all Selected BDCs and Selected Drug Candidates. For clarity, Research Compounds shall include Synthetic Cannabinoids synthesized under the Research Plan and which subsequently become Selected BDCs and/or Selected Drug Candidates.

Botanical Drug Candidate or BDC shall mean
—  any cannabinoid from a single chemovar of a chemically and genetically characterized Cannabis sativa plant (Phytocannabinoid) at any stage of research or development made using any extraction method and in any degree of purification in which only a single cannabinoid is present in a concentration which has the potential to be therapeutically active including, without limitation, the THC fraction and the CBD fraction separately; and
—  a combination of two or more Phytocannabinoid extracts described containing two or more Phytocannabinoids present in concentrations such that both have the potential to be therapeutically active mixed in a precise ratio i.e. the THC and CBD fractions mixed (without other fractions) in the ratio of THC CBD of 90 10. For clarity specifically excluded from the definition of BOC is any combination of the THC and CBD fractions when mixed (without other fractions) in a ratio of CBD to THC that falls inside the range of 2575 to 7525; and
— any biological or chemical modification of the Phytocannabinoids including any metabolite or degradant.

Synthetic Cannabinoid shall mean any Phytocannabinoid produced by synthetic methods either pursuant to a Research Plan (a Type 1 Synthetic Cannabinoid), or, outside of the Research Collaboration but with information resulting from the Research Collaboration (Type 2 Synthetic
Cannabinoid).

Synthetic Cannabinoid Product shall mean any pharmaceutical product containing a Type 1 Synthetic Cannabinoid (Type 1 Synthetic Product) or a Type 2 Synthetic Cannabinoid (Type 2 Synthetic Cannabinoid Product).

Synthetic Molecule shall mean a synthetic molecule whose chemistry is not based on a Phytocannabinoid but;
—  which has been developed with information resulting from the Research Collaboration and,
—  for which one or more patent· applications have been filed by Licensee on an invention conceived within three years following expiration of the Research Term or any Extended Research Term claiming a novel composition of matter and a cannabinomimetic or cannabinergic effect through direct, or indirect (i.e. modulation of related metabolic enzyme systems), effects on one or more cannabinoid receptors (including their allosteric sites).

Synthetic Molecule Product shall mean any pharmaceutical product containing a Synthetic Molecule.

Field of Use

The field of use is neuropsychopharmacology, with special reference to schizophrenia, cannabinoid/opioid analgesic combinations, and, oncology.

Research Field shall mean the treatment, diagnosis, prevention, or palliation of diseases, conditions, syndromes, and maladies of the central and peripheral nervous. systems of humans and animals and cancer in humans and animals.

License Grant

The Netherlands Licensor and Licensee collaborate research in respect of the Project Technology Results, Licensor Identified Targets and/or Non-Licensor Identified Targets.

Licensor hereby assigns, transfers and conveys to XXII all right, title and interest in and to the Results. Licensor shall execute and deliver to XXII such documents, instrument and other writings reasonably requested by XXII to vest all right, title and interest in the Results in XXII.

License Property

Licensor Identified Targets means Results that constitute or are based on genes, alleles and other regulatory elements that are identified by Licensor in the course of a Project (i.e. KeySeeQ output), other than publicly known regulatory elements.

Non-Licensor Identified Targets means Results that constitute or are based on genes, alleles and other regulators that are publicly known regulatory elements.

Project Technology Results means (i) any and all protocols, methods, procedures, know-how, software, inventions, technologies and/or combinations thereof, whether in electronic form or not and whether or not laid down in protocols that (A) is developed, created and/or generated by Licensor from the execution of a Project, (B) is applicable to the Field, and (C) is expressly a deliverable of a Project as further detailed in a PAS and/or is otherwise expressly agreed by the Parties prior to the commencement of a respective Project as being a Project Technology Result, unless otherwise agreed to in writing by the Parties after the commencement of a Project and (ii) any other protocols, methods, procedures or technologies that may be separately approved by the Steering Committee as Project Technology Results.

Licensor is a global leader in plant research involving high-value genetic traits and increased crop yields.

The focus of the collaboration will include
(i) Creating a cutting-edge genetic database which utilizes the results of genomic analyses of several hundred existing, exceptional hemp/cannabis plant lines for use in the acceleration of the Company’s development and licensing of uniquely characterized and improved hemp/cannabis plants;

(ii) Enhancing genetic variation to empower Licensee’s development of new and significantly improved varieties of hemp/cannabis plant lines and varieties with highly desirable cannabinoid profiles optimized for medicinal or therapeutic applications;

(iii) Creating a proprietary and industry-leading high-resolution “molecular genetic map” of the entire cannabis plant genome to facilitate rapid, cost-effective breeding of innovative varieties of hemp/cannabis plants with distinctive agronomic traits;

(iv) Analyzing the genomic sequences of multiple species of the hemp/cannabis plant and identifying shared genetic markers, allowing Licensee to develop improved commercial hemp/cannabis plant lines more rapidly than through conventional plant breeding approaches; and

(v) Initiating the rapid-cycle generation of hemp/cannabis plant lines with distinctive cannabinoid and terpene profiles to create elite lines.

Field of Use

Field means any and all use of, research regarding, and/or commercialization of hemp and/or cannabis (all versions and types of the genus Cannabis Sativa L plant), and/or any parts thereof, for any and all purposes, including but not limited to human, medical, agricultural, veterinary, therapeutic and other such purposes.

Licensor provides Licensee access to a unique suite of crop innovation platforms, including genomics, molecular genetics, trait discovery and breeding technologies.

License Grant

The Licensee entered into a perpetual license agreement with the Licensor to make use of the Licensor's intellectual property for the cultivation of cannabis and extraction of oils and other strains of cannabis.

License Property

Licensor has developed certain proprietary know-how and other intellectual property for the cultivation of cannabis and the extraction of oils and other constituents from cannabis (the 'Intellectual Property').

Field of Use

The Licensee will use the technology for cannaibis operations within the state of Nevada.

License Grant

The Israeli Licensor and the Cayman Islands Licensee hereby agree to the amendment of the License Agreement (the 'First Amendment') to amend the product definition and the royalty consideration for Over the Counter Pharmaceutical Products.

License Property

Pharmaceutical Product shall mean, with respect to each jurisdiction in which it is sold or intended for sale (the 'Applicable Jurisdiction'), any cannabis-based product, compound or medicine which under the laws of the Applicable Jurisdiction would be regulated and subject to approval and restrictions in the same manner and degree and for specific indications as an approved or registered pharmaceutical product (“Pharmaceutical-Level Regulation”), whether or not prescribed or used for that specific indication, and whether used or sold pursuant to a prescription or over the counter; provided, however, that for purposes of this Agreement (a) the following shall not be considered a “Pharmaceutical Product” (i) cannabis plants (including flowers) in their natural form; (ii) food supplements containing cannabis as part of their ingredients, unless they are subject in the Applicable Jurisdiction to Pharmaceutical-Level Regulation; (iii) cosmetic products containing cannabis as part of their ingredients, unless they are subject in the Applicable Jurisdiction to Pharmaceutical-Level Regulation; and (iv) cannabis-based toothpastes, (b) cannabis-based extracts, oils and mixtures shall not be considered a “Pharmaceutical Product”, unless and to the extent such extracts, oils or mixtures are or were subject in the Applicable Jurisdiction to Pharmaceutical-Level Regulation or have potency levels equal to or higher than an identical or substantially similar product which is subject in the Applicable Jurisdiction to Pharmaceutical-Level Regulation, and (c) notwithstanding the foregoing, in the event that identical or substantially similar cannabis-based products can be sold in any Applicable Jurisdiction as both a pharmaceutical product which is subject to Pharmaceutical-Level Regulation and as a medical or adult use cannabis product which is not subject to Pharmaceutical-Level Regulation, for purposes of this Agreement, the form of such cannabis-based product which is permitted to be sold without being subject to Pharmaceutical-Level Regulation shall not be considered a “Pharmaceutical Product”. '

Field of Use

Licensee is an early stage biopharmaceutical company engaged in the business of discovering, developing and commercializing drugs containing cannabinoids, which are based on a proprietary cannabinoid-based product platform, for the treatment of various diseases, disorders and medical conditions.

License Grant

The Canadian Company obtained an exclusive licence to exploit exclusive varieties of cannabis and access to extensive data that Licensor had gathered from thousands of its patients for over a decade.

License Property

Licensor is a research and development-driven company dedicated to patient care, scientific innovation, research and advancing the understanding of the therapeutic benefits of cannabis.

Field of Use

This agreement pertains to the drug industry relating to the cannabis market.

License Grant

The Licensor and Licensee amended their Agreement and expanded the scope of their partnership.The amended Agreement calls for the Licensor to serve as the developer of a new facility to be called the Illinois Medical Cannabis Center. The Licensee plans to use the IMCC to cultivate,process and distribute medical cannabis to many of the state's 52 newly Licensed medical dispensaries.  
Licensor will receive royalties and consulting fees.

License Property

When fully constructed,the IMCC will contain approximately 285,000 square feet capable of producing an estimated 50,000 pounds annually of medical cannabis owned by the Licensor. Licensor will provide working capital funding and horticultural assistance to the Licensor.

Field of Use

Medical cannabis distribution.

License Grant

The Parties entered into a non-exclusive license agreement for the Licensors patent and technology.

License Property

The license is for super-critical fluid cannabis extraction patents which cover methods enabled by the licensee’s extraction equipment.

Field of Use

The Licensee has the rights to Licensor's portfolio of issued and pending process and composition patents for isolating cannabinoids using an advanced supercritical fluid extraction technology utilizing carbon dioxide as the solvent. While the patents cover the incorporation of cannabis extracts into multiple dosage forms, CURE has reserved all rights to applying these methods in oral thin film.

The Licensee is a botanical extraction equipment manufacturer.

License Grant

The Parties hereby agree to form a Delaware Limited Liability Company to pursue the Business Opportunities and developing additional markets for the sale of the Products in various states in the United States of America. Licensor will provide the undisclosed New Company with devices specifically configured for hemp/CBD and the New Company will have the exclusive right to that configuration in the defined geographic area. Licensor will design and build the equipment necessary for the manufacturing of the Consumables and contribute that equipment to New Company. Licensor will license its intellectual property to the New Company as necessary.

License Property

Licenors Technology means the developed and patented “heat not burn” technology which allows hemp/CBD to be ingested via inhalation without the necessity of burning the organic product technology and patents include an activator device that provides the heat (“Device”) and consumable packets containing a susceptor as the heating element and the hemp/CBD to be heated (“Consumables”).

Field of Use

Field of use is for creating hemp/CBD to be ingested via inhalation.

License Grant

Licensor granted Canadian Licensee an exclusive 10-year license to use our brands, formulations and other intellectual property to make, use and sell “THC Cannabis Beverage Products” within the states of California, Oregon and Nevada.

License Property

THC Cannabis Beverage Products are the THC-infused beverages that consist of (a) High Life THC infused cocktails, (b) Arvo THC Infused Seltzer, (c) Zen THC Infused Seltzer, (d) Life Brew, non-alcoholic THC infused beer drink, (e) Island THC infused Coconut Water, (f) Stoney Island THC Cold Brew Coffee, (g) 420 Friendly THC Lemonades, (h) California THC Bitters and (i) other related THC infused beverages developed by the Company that may be sold and distributed by Licensee or its affiliates within California, Oregon and Nevada.

Field of Use

Field of use is in the beverage industry.

License Grant

The subsidiary will assume the manufacturing, sale and distribution of the pet supplement business and manage the production facility in Washington State from the Canadian Parent.  The net operating profit and loss sharing arrangement was terminated.

License Property

The business is in the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets of high CBD hemp and other flora and offering full spectrum DNA testing for plant identification, live genetics preservation using  low temperature storage for various cannabis and horticulture plants; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American high CBD hemp, Cannabis and agriculture sectors.

Field of Use

This agreement pertains to the drug industry.

License Grant

Licensor hereby grants Licensee, including Licensees Affiliates,

(a) during the Term, a royalty-bearing, Territory-wide license in the Licensed Field under the Patent Rights to the Licensed Technology, as well as under the Licensed Patents, the Licensed Know-how, and the Licensed Technology, regardless of whether such Licensed Patents are actually granted, to use the Licensed Know-how and Licensed Technology and to develop and have developed, make and have made, use and have used, sell and have sold, offer for sale and have offered for sale, import and have imported, export and have exported, any and all inventions claimed in the Licensed Patents related to the Licensed Products and/or any compounds, chemicals, substrates, devices, tools, dies, molds or any other materials whatsoever that are useful in the development and/or manufacturing and/or sale of the Licensed Products, and particularly including, without limitation, such license to develop and have developed, make and have made, use and have used, sell and have sold, offer for sale and have offered for sale, import and have imported, export and have exported Licensed Products, which license shall be exclusive even as to Licensor, and

(b) the right to grant bona fide sublicenses to third parties, to develop and have developed, to make and have made, use and have used, sell and have sold, import and have imported, export and have exported, Licensed Products, and to exercise all other rights under the License; provided, however, Licensee shall not have the right to grant any sublicense or to transfer any of its rights under the License unless each such sublicense or other transfer granted by Licensee contains terms and conditions under which the Sublicensee or transferee will be bound in the same manner as Licensee is under this Agreement. A copy of the proposed agreement shall be provided to Licensor prior to the execution of the Agreement.

License Property

Lcensed Products shall mean any and all products comprising tablets with Cannabinoids) utilizing the Licensed Technology for the delivery of a recreational, Medicinal or Pharmaceutical Cannabinoids product in specific dosage forms.

Cannabinoids means any of the chemical compounds that are the active components of the Cannabis genus of plants and its three species, Cannabis sativa, Cannabis indica, and Cannabis ruderalis; whether the compounds are synthetically produced or plant-derived, as well as cannabinoid compounds, formulations or products, that include single and/or multiple Cannabinoids including both synthetic and plant-derived Cannabinoids, as well as any and all Cannabinoid analogues. For formulations or compounds which may include combinations of API’s, other than Cannabinoids or terpenes, it is being agreed that if the API is another FDA approved Pharmaceutical, Licensor approval will be required to ensure that the API is not the subject of a current Licensor product, or the product of another licensee of the Licensor.

Medicinal shall mean any product containing marijuana, hemp or cannabis produced and sold for health, wellness, or nutritional purposes, including as herbal medicine, including products produced or sold through U.S. state-licensed or regulated marijuana programs and comparable programs in other countries and jurisdictions.

Licensed Technology shall mean the aggregate of the Licensed Inventions, the Licensed Know-how, the Licensed Products and the Licensed Patents and any other information and/or technology related to the Licensed Products and/or the design and/or the manufacturing of the Licensed Products

Licensed Patents shall mean any and all rights arising out of or resulting from (i) the patents and patent application set forth in Schedule 1.14 attached to this Agreement, as well as any additional patents or patent applications related to any aspect of any Licensed Technology Improvements, Licensed Know-how, Licensed Products, and/or Licensed Technology (as herein defined) filed prior to or during the term of this Agreement and (ii) any patent granted in respect of all such applications, as well as, without limitation, any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, re-examinations, extensions, supplementary protection certificates, confirmations, registrations, revalidations and the like, of any and all such patents and patent applications and any international equivalents thereof.

Field of Use

Licensed Field shall mean the use of Cannabinoids, together with the Licensed Technology for recreational, Medicinal and Pharmaceutical purposes in humans and animals.

License Grant

In this agreement the Licensee is to produce cannabis-infused baked goods and other edibles in Licensor’s production facility upon approval of Licensor’s Nevada Medical Marijuana Production License.

License Property

The Company (Licensor) seeks to be an innovative technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a variety of ailments. The Company is developing and utilizing state of the art technologies in plant biology, cultivation and extraction techniques, combined with biotechnology, and plans to produce consistent and measurable medical-grade cannabis, cannabis concentrates and cannabinoid therapies.

Field of Use

This agreement pertains to the drug industry relating to cannabis-based therapeutic products.